C20ORF4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.150800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.474400E-01
Normal-vs-Stage2
5.023200E-01
Normal-vs-Stage3
1.207360E-01
Normal-vs-Stage4
5.365800E-01
Stage1-vs-Stage2
7.279200E-01
Stage1-vs-Stage3
1.924370E-01
Stage1-vs-Stage4
8.729800E-02
Stage2-vs-Stage3
6.881500E-02
Stage2-vs-Stage4
1.765040E-01
Stage3-vs-Stage4
5.115500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.031000E-01
Normal-vs-AfricanAmerican
9.535000E-01
Normal-vs-Asian
3.450000E-01
Caucasian-vs-AfricanAmerican
3.864800E-01
Caucasian-vs-Asian
5.121000E-01
AfricanAmerican-vs-Asian
2.528600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.013000E-01
Normal-vs-Female
6.782000E-01
Male-vs-Female
9.283700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.756600E-01
Normal-vs-Age(41-60Yrs)
7.606400E-01
Normal-vs-Age(61-80Yrs)
4.475000E-01
Normal-vs-Age(81-100Yrs)
2.079800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.741600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.029200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.403400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.484200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.658610E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.611600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.368000E-02
Normal-vs-Daily Drinker
6.846600E-01
Normal-vs-Weekly Drinker
7.685400E-01
Normal-vs-Occasional Drinker
9.840400E-01
Normal-vs-Social Drinker
8.811000E-01
Non Drinker-vs-Daily Drinker
1.025530E-02
Non Drinker-vs-Weekly Drinker
9.600400E-02
Non Drinker-vs-Occasional Drinker
9.019100E-04
Non Drinker-vs-Social Drinker
2.861300E-03
Daily Drinker-vs-Weekly Drinker
9.891600E-01
Daily Drinker-vs-Occasional Drinker
4.529400E-01
Daily Drinker-vs-Social Drinker
6.123600E-01
Weekly Drinker-vs-Occasional Drinker
5.727600E-01
Weekly Drinker-vs-Social Drinker
7.076600E-01
Occasional Drinker-vs-Social Drinker
8.278600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.073600E-01
Normal-vs-Grade 2
9.449800E-01
Normal-vs-Grade 3
9.588400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.919000E-01
Grade 1-vs-Grade 3
2.537400E-01
Grade 1-vs-Grade 4
9.073600E-01
Grade 2-vs-Grade 3
6.304000E-01
Grade 2-vs-Grade 4
9.449800E-01
Grade 3-vs-Grade 4
9.588400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.791800E-01
Normal-vs-NonDiabetic
6.017800E-01
Diabetic-vs-NonDiabetic
3.038000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.557600E-01
Normal-vs-NoPancreatitis
4.802000E-01
Pancreatitis-vs-NoPancreatitis
4.864200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.009200E-01
Normal-vs-N1
5.534600E-01
N0-vs-N1
6.994000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.482600E-01
Normal-vs-TP53-NonMutant
5.594400E-01
TP53-Mutant-vs-TP53-NonMutant
1.293360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
